Yanbin Xiao
P.R. China
Kunming, 650118, China
Kunming, 650118, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
3D-Printed prosthesis for recurrent femoral metastasis with periprosthetic infection: A case report.
3D-Printed prosthesis for recurrent femoral metastasis with periprosthetic infection: A case report.
Journal: Experimental and therapeutic medicine
Published: September 14, 2025
Customized high-throughput microfluidic production of multifunctional porous microspheres for bone repair.
Journal: Biomaterials advances
Published: May 22, 2025
Deep learning algorithms from histopathological images stratify molecular subtypes for leiomyosarcoma: a proof-and-concept diagnostic study.
Journal: International journal of surgery (London, England)
Published: April 14, 2025
Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study.
Journal: Nature communications
Published: January 31, 2024
Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.
Journal: The Journal of international medical research
Published: January 12, 2021
Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.
Journal: Clinical, cosmetic and investigational dermatology
Published: September 23, 2020
miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy.
Journal: OncoTargets and therapy
Published: June 19, 2019
EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma.
Journal: British journal of cancer
Published: April 20, 2019
LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo.
Journal: OncoTargets and therapy
Published: July 23, 2016
Lentiviral-mediated overexpression of long non-coding RNA GAS5 reduces invasion by mediating MMP2 expression and activity in human melanoma cells.
Journal: International journal of oncology
Published: December 01, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026